125 related articles for article (PubMed ID: 20224859)
21. Medullary thyroid carcinoma: surgical management of primary tumor and locoregional recurrence.
Bellantone R; Boscherini M; Lombardi CP; Alesina PF
Rays; 2000; 25(2):267-71. PubMed ID: 11370544
[TBL] [Abstract][Full Text] [Related]
22. Medullary thyroid carcinoma presenting with an initial CEA elevation.
Abraham D; Delbridge L; Clifton-Bligh R; Clifton-Bligh P; Grodski S; Robinson BG; Messina M; Sidhu S
ANZ J Surg; 2010 Nov; 80(11):831-3. PubMed ID: 20969693
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report.
Bagherzadeh M; Aminorroaya A; Vafaeimanesh J; Mohajeri-Tehrani MR
J Med Case Rep; 2018 Aug; 12(1):220. PubMed ID: 30107852
[TBL] [Abstract][Full Text] [Related]
24. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
25. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
Chi DD; Moley JF
Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical analysis of fine needle aspiration cytology to improve surgical strategy in thyroid neoplasms.
Pisani T; Vecchione A; Giovagnoli MR
Acta Cytol; 2003; 47(3):520-2. PubMed ID: 12789946
[No Abstract] [Full Text] [Related]
27. [Main causes of reoperation in patients with thyroid cancer].
Romanchisen AF
Vestn Khir Im I I Grek; 1998; 157(2):11-3. PubMed ID: 9691372
[TBL] [Abstract][Full Text] [Related]
28. Medullary thyroid carcinoma: a 20-year experience from a centre in South India.
Finny P; Jacob JJ; Thomas N; Philip J; Rajarathnam S; Oommen R; Nair A; Seshadri MS
ANZ J Surg; 2007 Mar; 77(3):130-4. PubMed ID: 17305985
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of 44 cases of recurrent thyroid carcinoma].
Zhao WC
Ai Zheng; 2003 Oct; 22(10):1102-4. PubMed ID: 14558962
[TBL] [Abstract][Full Text] [Related]
30. PET imaging of recurrent medullary thyroid cancer.
Simon GH; Nitzsche EU; Laubenberger JJ; Einert A; Moser E
Nuklearmedizin; 1996 Jun; 35(3):102-4. PubMed ID: 8710526
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of clinical, histopathological and immunohistochemical features in medullary thyroid cancer].
Ríos A; Rodríguez JM; Febrero B; Acosta JM; Torregrosa N; Parrilla P
Med Clin (Barc); 2012 Sep; 139(7):277-83. PubMed ID: 22032817
[TBL] [Abstract][Full Text] [Related]
32. Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience.
Dorairajan N; Siddharth D; Kanna S
Int Surg; 2006; 91(3):162-7. PubMed ID: 16845858
[TBL] [Abstract][Full Text] [Related]
33. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
34. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
Shaha AR; Cohen T; Ghossein R; Tuttle RM
Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
[TBL] [Abstract][Full Text] [Related]
35. [Hyperthyroidism and carcinoma of the thyroid gland].
Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
[TBL] [Abstract][Full Text] [Related]
36. [Primary cancer of the thyroid: natural history and therapy principles].
Veroux P; Fazzi C; Nicosia AS; Veroux M; Cannizzaro MA
Chir Ital; 1997; 49(1-2):15-27. PubMed ID: 12743871
[TBL] [Abstract][Full Text] [Related]
37. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
38. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Meijer JA; le Cessie S; van den Hout WB; Kievit J; Schoones JW; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2010 Apr; 72(4):534-42. PubMed ID: 19563448
[TBL] [Abstract][Full Text] [Related]
39. Expression and significance of c-met protein in papillary thyroid carcinoma.
Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
[TBL] [Abstract][Full Text] [Related]
40. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
